metricas
covid
Medicina Clínica (English Edition) Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A s...
Journal Information

Statistics

Follow this link to access the full text of the article

Scientific letter
Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
Tocilizumab más glucocorticoides para tratar pacientes graves y en situación crítica infectados por COVID-19. Experiencia de un centro
Gustavo Jiménez-Bríteza,b,
Corresponding author
gustavo.jimenezb@quironsalud.es

Corresponding author.
, Pablo Ruiza, Xavier Solera
a Intensive Care Unit, Centro Médico Teknon, Quironsalud, Barcelona, Spain
b Facultad de Ciencias de la Salud, Universidad Nacional del Este (FACISA-UNE), Paraguay
Read
105
Times
was read the article
0
Total PDF
105
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 10 8 0 8
2025 9 6 0 6
2025 8 9 0 9
2025 7 9 0 9
2025 6 5 0 5
2025 5 4 0 4
2025 4 1 0 1
2025 3 3 0 3
2025 2 2 0 2
2025 1 3 0 3
2024 12 1 0 1
2024 11 1 0 1
2024 9 1 0 1
2024 8 1 0 1
2024 7 1 0 1
2024 6 1 0 1
2024 5 2 0 2
2024 4 1 0 1
2024 2 1 0 1
2024 1 2 0 2
2023 12 4 0 4
2023 11 1 0 1
2023 10 1 0 1
2023 9 3 0 3
2023 8 1 0 1
2023 6 2 0 2
2023 5 1 0 1
2023 4 2 0 2
2023 3 1 0 1
2023 2 1 0 1
2022 12 1 0 1
2022 11 2 0 2
2022 10 2 0 2
2022 9 4 0 4
2022 8 3 0 3
2022 7 2 0 2
2022 6 2 0 2
2022 5 2 0 2
2022 4 4 0 4
2022 3 2 0 2
2022 2 2 0 2
Show all

Follow this link to access the full text of the article